Jeffrey V Ravetch

35PUBLICATIONS
152CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Aug 07, 2026
Mechanisms of antibody-mediated enhancement of immune responses.

|Jul 27, 2026
Cancer immunotherapy targeting murine myeloid cells requires endosomal pattern recognition.

|Apr 08, 2026
Selective depletion of virus-specific CD8 T cells from the liver after PD-1 therapy with Fc-intact antibody during chronic infection.

Masao Hashimoto, Tahseen H Nasti, Hyun-Tak Jin

|Dec 16, 2025
Antibody-lectin chimeras for glyco-immune checkpoint blockade.

Jessica C Stark, Melissa A Gray, Itziar Ibarlucea-Benitez

|Dec 12, 2025
Asymmetrically glycosylated IgG1 antibodies are universal and drive human disease.

Tala Azzam, Stylianos Bournazos, Hasret Gunduz

|Nov 06, 2025
The anti-inflammatory activity of IgG is enhanced by co-engagement of type I and II Fc receptors.

Andrew T Jones, Alessandra E Marino, Tetyana Martynyuk

Pageof 6

Frequent Collaborators

10 joint publications

Stylianos Bournazos

4 joint publications

Eric J Sundberg

3 joint publications

David A Knorr

3 joint publications

Jonathan J Du